Back
Delegates Premium Access

Assessment of CV risk by SCORE2 with an online calculator estimates CV risk better compared to 2-dimensional risk charts

Session: Estimating cardiovascular risk: does one score fit all?
Topic: Cardiovascular Risk Assessment
Speaker: Doctor S. Hageman (Utrecht, NL)
Event: ESC Preventive Cardiology 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Steven Hageman

University Medical Center Utrecht, Utrecht (Netherlands (The))
3 presentations
0 follower

6 more presentations in this session

Combining the systematic coronary risk evaluation (SCORE2-SCORE2-OP) with anthropometric measures to refine 10-year cardiovascular prediction in a population-based cohort study

Speaker: Miss J. Lopes Oliveira (Lausanne, CH)

Access
Abstract
Slides
Like
Thumbnail

Risk stratification in chronic coronary syndrome: real-world application of SMART and EUROASPIRE scores for treatment optimization

Speaker: Assistant Professor M. German-Sallo (Targu Mures, RO)

Access
Abstract
Slides
Like
Thumbnail

Validation of the European SCORE2 algorithm in four European and non-European cohort studies with contrasting populations

Speaker: Doctor K. Maung (Lausanne, CH)

Access
Abstract
Slides
Like
Thumbnail

Risky business: exploring statin eligibility across nine cardiovascular risk prediction models

Speaker: Mr P. Navickas (Vilnius, LT)

Access
Abstract
Slides
Like
Thumbnail

Validation of cardiovascular disease risk prediction models using population-wide electronic health records for England post COVID-19 pandemic: the SCORE2 family-of-models

Speaker: Miss C. Petitjean (Cambridge, GB)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Estimating cardiovascular risk: does one score fit all?

Speakers: Doctor S. Hageman, Miss J. Lopes Oliveira, Assistant Professor M. German-Sallo, Doctor K. Maung, Mr P. Navickas...
Access
Like
Thumbnail

About the event

Image

ESC Preventive Cardiology 2025

3 April - 5 April 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources